Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > Paladin labs comparison to Knight

<< Previous

Bullboard Posts

Next >>

Post by GoldenInvestoron Sep 07, 2022 11:58am

182 Views

Post# 34946840

Paladin labs comparison to Knight

In 2011, Paladin recorded revenues of $141.5 milliion, a RECORD revenue increase of 11% YOY!

In 2021, Knight Therapeutics recorded record revenuew of $243.5 Million, a RECORD revnue increase of 22% YOY!

Knight has now had the LAtam operations under management and growing both canada and latam.

It seems knight is growing faster than its predecessor, in more countries by a significant margin!

Please critique.

GI

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China